SynthesisActa diabetologica2021
Efficacy, safety, and user experience of DIY or open-source artificial pancreas systems: a systematic review.
Synthesis in Acta diabetologica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Trial
- Hybrid Closed Loop Using a Do-It-Yourself Artificial Pancreas System in Adults With Type 1 Diabetes.Journal of diabetes science and technology · 2024Trial
- Bridging the Digital Divide: Real-World Efficacy of Commercial and Open-Source Automated Insulin Delivery Systems in a Diverse, Low-Resource Pediatric Population.Journal of diabetes science and technology · 2026Article
- Safety and glycemic outcomes of DBLG1 coupled to the DANA-i pump in adults and adolescents with type 1 diabetes mellitus. The SP8 trial.Journal of endocrinological investigation · 2026Article
- Article
- Accuracy of an Off-Label Transmitter and Data Manager Paired With an Intermittent Scanned Continuous Glucose Monitor in Adults With Type 1 Diabetes.Journal of diabetes science and technology · 2024Article
- The changing landscape of automated insulin delivery in the management of type 1 diabetes.Endocrine connections · 2023Review
- Interviews with Indigenous Māori with type 1 diabetes using open-source automated insulin delivery in the CREATE randomised trial.Journal of diabetes and metabolic disorders · 2023Article
- Practical Guidance on Open Source and Commercial Automated Insulin Delivery Systems: A Guide for Healthcare Professionals Supporting People with Insulin-Requiring Diabetes.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2022Article
- Review of Automated Insulin Delivery Systems for Type 1 Diabetes and Associated Time in Range Outcomes.TouchREVIEWS in endocrinology · 2022Review
- Large-Scale Data Analysis for Glucose Variability Outcomes with Open-Source Automated Insulin Delivery Systems.Nutrients · 2022Article
- Use of automated insulin delivery systems in people with type 1 diabetes fasting during Ramadan: An observational study.Journal of diabetes investigation · 2022Observational
- Closed-Loop Insulin Delivery Systems: Past, Present, and Future Directions.Frontiers in endocrinology · 2022 · on this mapReview
- Mapping the Landscape of Do-it-Yourself Medicine.Citizen science : theory and practice · 2022Article
- Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals.The lancet. Diabetes & endocrinology · 2022Review
- Barriers to Uptake of Open-Source Automated Insulin Delivery Systems: Analysis of Socioeconomic Factors and Perceived Challenges of Caregivers of Children and Adolescents With Type 1 Diabetes From the OPEN Survey.Frontiers in clinical diabetes and healthcare · 2022Article
- Fault Tolerant Strategies for Automated Insulin Delivery Considering the Human Component: Current and Future Perspectives.Journal of diabetes science and technology · 2021Review
- How It Started, How It Is Going: The Future of Artificial Pancreas Systems (Automated Insulin Delivery Systems).Journal of diabetes science and technology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The do-it-yourself artificial pancreas system (DIYAPS) is a patient-driven initiative with the potential to revolutionise diabetes management, automating insulin delivery with existing pumps and CGM combined with open-source algorithms. Given the considerable interest in this topic within the diabetes community, we have conducted a systematic review of DIYAPS efficacy, safety, and user experience. Following recognised procedures and reporting standards, we identified 10 eligible publications of 730 participants within the peer-reviewed literature. Overall, studies reported improvements in time in range, HbA1c (glycated haemoglobin), reduced hypoglycaemia, and improved quality of life with DIYAPS use. While results were positive, the identified studies were small, and the majority were observational and at high risk of bias. Further research including well-designed randomised trials comparing DIYAPS with appropriate comparators is recommended.
Indexed as
Identifiers
33128136What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.